跳至主要内容
临床试验/NCT06340438
NCT06340438招募中不适用

Investigation of the Neurophysiological and Psychological Aspects of Itch

Aalborg University2 个研究点 分布在 1 个国家目标入组 46 人开始时间: 2024年4月27日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
46
试验地点
2
主要终点
Reinforcement Sensitivity Theory - Personality Questionnaire (RST-PQ).

研究概览

简要总结

This project aims to investigate the relationship between different dimensions of catastrophizing (rumination, magnification, and helplessness) as well as some specific personality traits related to catastrophizing tendencies like anxiety sensitivity and fear sensitivity in the modulation of itch and pain intensities in an experimental setting.

详细描述

Chronic itch severely affects the quality of life of patients by interfering with vital functions such as sleep, attention, and sexual activity, with an elevated expression of cognitive and emotional factors such as itch catastrophizing, worrying, as well as personality characteristics such as the predisposition to anxiety, depression, and suicidal thoughts that play an important role in the development, modification, and maintenance of itch. Moreover, chronic itch represents a significant socioeconomic burden due to a prevalence of around 10% in combination with largely suboptimal treatment since limited evidence has been found for the effectiveness of pharmaceutical interventions. The hypothesis of this project is that since it is well documented that the relationship between catastrophizing and pain and that itch and pain share many similarities, investigators can assume the existence of a similar connection between catastrophizing and itching.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Single (Participant)

盲法说明

Participant will be blinded about application of pruritogens.

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy men and women
  • 18-60 years
  • Speak and understand English

排除标准

  • Pregnancy or lactation
  • Drug addiction defined as any use of cannabis, opioids, or other addictive drugs
  • Previous or current history of neurological (e.g. neuropathy), immunological (e.g. asthma, immune deficiencies, arthritis), musculoskeletal (e.g. muscular pain in the upper extremities,), cardiac disorder, or mental illnesses that may affect the results
  • Lack of ability to cooperate
  • Current use of medications that may affect the trial such as antihistamines, antipsychotics, and pain killers, as well as systemic or topical steroids
  • Skin diseases (e.g. atopic dermatitis, pruritus nodularis, eczema, psoriasis)
  • Moles, scars, or tattoos in the area to be treated or tested.
  • Consumption of alcohol or painkillers 24 hours before the study days and between these
  • Acute or chronic pain
  • Participation in other trials within one week of study entry (four weeks in the case of pharmaceutical trials)

结局指标

主要结局

Reinforcement Sensitivity Theory - Personality Questionnaire (RST-PQ).

时间窗: Baseline 1st session

The Reinforcement Sensitivity Theory - Personality Questionnaire contains the following subscales: the Fight-Flight-Freeze System (FFFS, 10 items); the Behavioral Inhibition System (BIS, 23 items); and the Behavioral Approach System (BAS, 32 items). In total, 65 items have to be answered on a 4-point Likert-type scale ranging from 1 (not at all) to 4 (Highly).

Pain Catastrophizing Scale (PCS).

时间窗: 10 minutes after every itch induction on 2nd session (3 days after 1st session)

The PCS assesses negative and exaggerated coping concerning anticipated or experienced painful stimuli. Thirteen items have to be answered on a 5-point Likert-type scale.

Learned Helplessness Scale (LHS)

时间窗: 10 minutes after every itch induction on 2nd session (3 days after 1st session)

The questionnaire consists of 20 items, and the participant's response to each item is rated on a 4-point Likert scale ranging from strongly agree (1) to strongly disagree (4).

The Pittsburg Sleep Quality Index (PSQI)

时间窗: Baseline 1st session

The PSQI consists of 19 items generating seven component scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. The seven component scores can be summarized in a global score ranging from zero to 21 with higher scores reflecting a worse overall quality of sleep.

Positive And Negative Affect Schedule (PANAS)

时间窗: 10 minutes after every itch induction on 2nd session (3 days after 1st session)

PANAS measures positive and negative affect dimensions. Positive affects (PA) are defined as "the extent to which a person feels active, enthusiastic, and alert". Negative affect (NA) is a condition of "general distress and unpleasable engagement"

Itch Catastrophizing Scale (ICS).

时间窗: 10 minutes after every itch induction on 2nd session (3 days after 1st session)

The ICS assesses negative and exaggerated coping concerning anticipated or experienced itchy stimuli. Thirteen items have to be answered on a 5-point Likert-type scale.

Depression, Anxiety, Stress Scale (DASS-21)

时间窗: Baseline 2nd session (3 days after 1st session)

The questionnaire measures the magnitude of depression, anxiety, and stress. Each of these three subscales consists of 7 questions answered using a 0-3 Likert scale, with 0 meaning "it did not apply to me", and 3 meaning "it applied to me very much"

次要结局

  • Assessment of pain(1 minute after every itch inductions)
  • Assessment of itch(1 minute after every itch inductions)

研究者

发起方
Aalborg University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Silvia Lo Vecchio

Associate Professor

Aalborg University

研究点 (2)

Loading locations...

相似试验